Tonix Pharmaceuticals Holding Corp (TNXP)
0.1973
-0.01
(-3.38%)
USD |
NASDAQ |
Nov 22, 13:55
Tonix Pharmaceuticals Total Liabilities (Quarterly): 20.78M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 20.78M |
| June 30, 2024 | 28.20M |
| March 31, 2024 | 27.20M |
| December 31, 2023 | 48.93M |
| September 30, 2023 | 18.45M |
| June 30, 2023 | 19.27M |
| March 31, 2023 | 13.66M |
| December 31, 2022 | 18.51M |
| September 30, 2022 | 13.72M |
| June 30, 2022 | 16.38M |
| March 31, 2022 | 15.76M |
| December 31, 2021 | 22.18M |
| September 30, 2021 | 12.56M |
| June 30, 2021 | 8.672M |
| March 31, 2021 | 6.605M |
| December 31, 2020 | 10.54M |
| September 30, 2020 | 5.049M |
| June 30, 2020 | 4.773M |
| March 31, 2020 | 2.685M |
| December 31, 2019 | 5.141M |
| September 30, 2019 | 2.417M |
| June 30, 2019 | 2.186M |
| March 31, 2019 | 2.211M |
| December 31, 2018 | 2.655M |
| September 30, 2018 | 2.346M |
| Date | Value |
|---|---|
| June 30, 2018 | 2.513M |
| March 31, 2018 | 2.369M |
| December 31, 2017 | 2.138M |
| September 30, 2017 | 1.855M |
| June 30, 2017 | 1.854M |
| March 31, 2017 | 1.809M |
| December 31, 2016 | 2.149M |
| September 30, 2016 | 2.696M |
| June 30, 2016 | 4.284M |
| March 31, 2016 | 4.008M |
| December 31, 2015 | 6.756M |
| September 30, 2015 | 5.174M |
| June 30, 2015 | 4.684M |
| March 31, 2015 | 3.584M |
| December 31, 2014 | 3.45M |
| September 30, 2014 | 3.551M |
| June 30, 2014 | 2.401M |
| March 31, 2014 | 2.281M |
| December 31, 2013 | 2.224M |
| September 30, 2013 | 2.133M |
| June 30, 2013 | 2.278M |
| March 31, 2013 | 1.234M |
| December 31, 2012 | 1.158M |
| September 30, 2012 | 0.8643M |
| June 30, 2012 | 0.8108M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.685M
Minimum
Mar 2020
48.93M
Maximum
Dec 2023
15.95M
Average
14.74M
Median
Total Liabilities (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 969.40M |
| Geovax Labs Inc | 2.608M |
| Abbott Laboratories | 34.33B |
| Amicus Therapeutics Inc | 607.73M |
| United Therapeutics Corp | 1.022B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 94.99M |
| Shareholders Equity (Quarterly) | 74.21M |
| Debt to Equity Ratio | 0.1077 |
| Current Ratio | 3.329 |
| Net Debt Paydown Yield | -1.21% |